Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

PURPOSE: NCCTG (North Central Cancer Treatment Group) N9831 is the only randomized phase III trial evaluating trastuzumab added sequentially or used concurrently with chemotherapy in resected stages I to III invasive human epidermal growth factor receptor 2–positive breast cancer. PATIENTS AND METHO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Perez, Edith A., Suman, Vera J., Davidson, Nancy E., Gralow, Julie R., Kaufman, Peter A., Visscher, Daniel W., Chen, Beiyun, Ingle, James N., Dakhil, Shaker R., Zujewski, JoAnne, Moreno-Aspitia, Alvaro, Pisansky, Thomas M., Jenkins, Robert B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236650/
https://ncbi.nlm.nih.gov/pubmed/22042958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.7045
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados